Équilibre Biopharmaceuticals


Équilibre Biopharmaceuticals Corp. was established as an innovative biopharmaceutical company focused on identifying and developing high-potential drugs for patients who are treatment-resistant or unresponsive to other existing medications.

Industries

Employees

11-50

Links


Org chart

Philip A. Barach
Chairman & CEO
Collapse
Steven Gordon
Chief Operating Officer, Chief Legal & Compliance Officer
Amy Melsaether
SVP of Clinical Research
Kevin McCracken
SVP, Chemistry, Manufacturing & Controls
Meg Dodge
SVP of Corporate Strategy & Investor Relations

Board & advisors



Offices